ADRIAMYCIN METHOTREXATE HIGH-DOSE VERSUS ADRIAMYCIN METHOTREXATE MODERATE DOSE AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITIES - A RANDOMIZED STUDY

被引:67
作者
BACCI, G
GHERLINZONI, F
PICCI, P
VANHORN, JR
JAFFE, N
GUERRA, A
RUGGIERI, P
BIAGINI, R
CAPANNA, R
TONI, A
MERCURI, M
DALLARI, D
CAMPANACCI, M
机构
[1] UNIV BOLOGNA, IST ORTOPED RIZZOLI, CTR BONE TUMOR, VIA CODIVILLA 9, I-40136 BOLOGNA, ITALY
[2] UNIV BOLOGNA, IST ORTOPED RIZZOLI, ORTHOPAED CLIN 1, I-40136 BOLOGNA, ITALY
[3] ST RADBOUD HOSP, NIJMEGEN, NETHERLANDS
[4] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, HOUSTON, TX 77030 USA
[5] IST ORTOPED RIZZOLI, DEPT INTERNAL MED & ONCOL, BOLOGNA, ITALY
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 11期
关键词
D O I
10.1016/0277-5379(86)90142-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1337 / 1345
页数:9
相关论文
共 35 条
[1]   IMPROVED 3-YEAR DISEASE-FREE SURVIVAL IN OSTEOGENIC-SARCOMA - EFFICACY OF ADJUNCTIVE CHEMOTHERAPY [J].
BLEYER, WA ;
HAAS, JE ;
FEIGL, P ;
GREENLEE, TK ;
SCHALLER, RT ;
MORGAN, A ;
PENDERGRASS, TW ;
JOHNSON, FL ;
BERNSTEIN, ID ;
CHARD, RL ;
HARTMANN, JR .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1982, 64 (02) :233-238
[2]  
CAMPANACCI M, 1984, CANCER, V48, P1456
[3]   ADJUVANT CHEMOTHERAPY IN OSTEOGENIC-SARCOMA - THE TRIUMPH THAT ISNT [J].
CARTER, SK .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) :147-148
[4]  
CORTES EP, 1979, P AM ASSOC CANC RES, V20, P412
[5]  
DAHLIN DC, 1979, MAYO CLIN PROC, V54, P621
[6]   A CONTROLLED PILOT-STUDY OF HIGH-DOSE METHOTREXATE AS POSTSURGICAL ADJUVANT TREATMENT FOR PRIMARY OSTEO-SARCOMA [J].
EDMONSON, JH ;
GREEN, SJ ;
IVINS, JC ;
GILCHRIST, GS ;
CREAGAN, ET ;
PRITCHARD, DJ ;
SMITHSON, WA ;
DAHLIN, DC ;
TAYLOR, WF .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) :152-156
[7]  
EILBER FR, 1985, ASCO P C, V561, P144
[8]  
ETTINGER LJ, 1981, CANCER, V47, P248, DOI 10.1002/1097-0142(19810115)47:2<248::AID-CNCR2820470208>3.0.CO
[9]  
2-E
[10]  
GUERRA A, MODERN TRENDS ORTHOP, P179